Detalles de la búsqueda
1.
Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.
J Pharm Sci
; 111(10): 2652-2661, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35691607
2.
Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis.
Drug Deliv
; 29(1): 2846-2854, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36062490
3.
Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.
Pharmaceutics
; 14(11)2022 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36365193
4.
Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial.
Pharmaceutics
; 13(11)2021 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34834183
Resultados
1 -
4
de 4
1
Próxima >
>>